FDA Inspection 1031639 — Haupt Pharma Wolfratshausen GmbH
The FDA completed an inspection of Haupt Pharma Wolfratshausen GmbH on Oct 20, 2017 in Wolfratshausen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 20, 2017
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Wolfratshausen (Germany)